Is it time to move to nucleic acid amplification tests screening for pharyngeal and rectal gonorrhoea in men who have sex with men to improve gonorrhoea control?

The use of nucleic acid amplification tests (NAAT), as well as or in preference to culture for non-genital sites is now recommended both in Australia and overseas because of their greater sensitivity and improved specificity. A survey of 22 Australian sexual health clinics who each year test over 14500 men who have sex with men (MSM) show that culture remains the predominate method for detecting gonorrhoea at pharyngeal (64%) and rectal (73%) sites. This editorial discusses the potential disadvantages of using culture over NAAT in relation to optimal gonorrhoea control among MSM and advocates that significantly improved control would be achieved by moving to NAAT with the proviso that culture samples are taken wherever possible on NAAT-positive samples and from clients with urethritis to ensure continued surveillance for antimicrobial resistance.

[1]  F. Vernel-Pauillac,et al.  Evidence that the gonococcal porA pseudogene is present in a broad range of Neisseria gonorrhoeae strains; suitability as a diagnostic target , 2006, Pathology.

[2]  S. Liska,et al.  Nucleic Acid Amplification Tests in the Diagnosis of Chlamydial and Gonococcal Infections of the Oropharynx and Rectum in Men Who Have Sex With Men , 2008, Sexually transmitted diseases.

[3]  S. Garland,et al.  Screening for Neisseria gonorrhoeae and Chlamydia trachomatis in Men Who Have Sex With Men at Male-Only Saunas , 2003, Sexually transmitted diseases.

[4]  D. Whiley,et al.  Low positive predictive value of a nucleic acid amplification test for nongenital Neisseria gonorrhoeae infection in homosexual men. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  S. Garland,et al.  Exploring 'best practice' for nucleic acid detection of Neisseria gonorrhoeae. , 2008, Sexual health.

[6]  C. Kent,et al.  Use of NAATs for STD diagnosis of GC and CT in non-FDA -cleared anatomic specimens. , 2006, MLO: medical laboratory observer.

[7]  Anthony M. A. Smith,et al.  Clinical significance of questionnaire-elicited or clinically reported anorectal symptoms for rectal Neisseria gonorrhoeae and Chlamydia trachomatis amongst men who have sex with men. , 2008, Sexual health.

[8]  David W Smith,et al.  Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrhoeae in Australia: a position paper on behalf of the Public Health Laboratory Network. , 2005, Communicable diseases intelligence quarterly report.

[9]  J. Wallin,et al.  Pharyngeal neisseria gonorrhoeae: coloniser or pathogen? , 1979, British medical journal.

[10]  M. Unemo,et al.  A fast real-time polymerase chain reaction method for sensitive and specific detection of the Neisseria gonorrhoeae porA pseudogene. , 2006, The Journal of molecular diagnostics : JMD.

[11]  J. Bates,et al.  A real-time PCR assay for the detection of Neisseria gonorrhoeae in genital and extragenital specimens. , 2005, Diagnostic microbiology and infectious disease.

[12]  J M Kaldor,et al.  Incidence and risk factors for urethral and anal gonorrhoea and chlamydia in a cohort of HIV-negative homosexual men: the Health in Men Study , 2006, Sexually Transmitted Infections.

[13]  C. Ison,et al.  GC NAATs: is the time right? , 2006, Sexually Transmitted Infections.

[14]  S. Garland,et al.  Evaluation of opa-Based Real-Time PCR for Detection of Neisseria gonorrhoeae , 2005, Sexually transmitted diseases.

[15]  S. Garland,et al.  Sexually transmitted diseases in disadvantaged Australian communities. , 1997, JAMA.

[16]  J. Kaldor,et al.  A new national Chlamydia Sentinel Surveillance System in Australia: evaluation of the first stage of implementation. , 2010, Communicable diseases intelligence quarterly report.